Human cardiac 31P magnetic resonance spectroscopy at 7 tesla

Magnetic Resonance in Medicine

Volumn 72, Issue 2, 2014, Pages 304-315

  Rodgers, Christopher T ^a   Clarke, William T ^a   Snyder, Carl ^b   Vaughan, J Thomas ^b   Neubauer, Stefan ^a   Robson, Matthew D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

7 Tesla; cardiac; field strength; phosphorus

Indexed keywords

CHROMIUM COMPOUNDS; HEART; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY; METABOLITES; PHOSPHORUS;

7 TESLAS; CARDIAC; FIELD STRENGTHS; INTRINSIC SIGNAL; LOOK-LOCKER;

SIGNAL TO NOISE RATIO;

2,3 DIPHOSPHOGLYCERIC ACID; ADENOSINE TRIPHOSPHATE; ALPHA ADENOSINE TRIPHOSPHATE; BETA ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; GAMMA ADENOSINE TRIPHOSPHATE; PHOSPHORUS 31; UNCLASSIFIED DRUG; PHOSPHORUS; PHOSPHORUS DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CRAMER RAO UNCERTAINTY; EXCITATION; HEART; HEART MUSCLE; HUMAN; IMAGING AND DISPLAY; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; SIGNAL NOISE RATIO; STATISTICAL PARAMETERS; ADULT; ALGORITHM; MALE; METABOLISM; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TISSUE ENGINEERING; YOUNG ADULT;

ADULT; ALGORITHMS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MOLECULAR IMAGING; MYOCARDIUM; PHOSPHORUS COMPOUNDS; PHOSPHORUS ISOTOPES; RADIOPHARMACEUTICALS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE ENGINEERING; YOUNG ADULT;

EID: 84904502387     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.24922     Document Type: Article

References (63)

1. Bottomley PA,. NMR Spectroscopy of the human heart. In:, Harris RK, Wasylishen RE, editors. Encyclopedia of magnetic resonance. Chichester: John Wiley; 2009.
2. Neubauer S,. Mechanisms of disease-The failing heart-An engine out of fuel. N Engl J Med 2007; 356: 1140-1151.
3. Lee JH, Komoroski RA, Chu WJ, Dudley JA,. Methods and applications of phosphorus NMR Spectroscopy in vivo. Annu Rep NMR Spectrom 2012; 75: 115-160.
4. Hudsmith LE, Neubauer S,. Detection of myocardial disorders by magnetic resonance spectroscopy. Nat Clin Pract Cardiovasc Med 2008; 5: S49-S56.
5. Bottomley PA,. Noninvasive study of high-energy phosphate-metabolism in human-heart by depth-resolved P-31 NMR-spectroscopy. Science 1985; 229: 769-772.
6. Bottomley PA, Wu KC, Gerstenblith G, Schulman SP, Steinberg A, Weiss RG,. Reduced myocardial creatine kinase flux in human myocardial infarction an in vivo phosphorus magnetic resonance spectroscopy study. Circulation 2009; 119: 1918-1924.
7. Rider OJ, Francis JM, Ali MK, Holloway C, Pegg T, Robson MD, Tyler D, Byrne J, Clarke K, Neubauer S,. Effects of catecholamine stress on diastolic function and myocardial energetics in obesity. Circulation 2012; 125: 1511-1519.
8. Holloway CJ, Suttie J, Dass S, Neubauer S,. Clinical cardiac magnetic resonance spectroscopy. Prog Cardiovasc Dis 2011; 54: 320-327.
9. Redpath TW,. Signal-to-noise ratio in MRI. Br J Radiol 1998; 71: 704-707.
10. De Graaf RA,. In vivo NMR spectroscopy: principles and techniques. Chichester: John Wiley and Sons; 2007.
11. Moser E,. Ultra-high-field magnetic resonance: why and when? World J Radiol 2010; 2: 37-40.
12. Tyler DJ, Emmanuel Y, Cochlin LE, Hudsmith LE, Holloway CJ, Neubauer S, Clarke K, Robson MD,. Reproducibility of 31P cardiac magnetic resonance spectroscopy at 3T. NMR Biomed 2009; 22: 405-413.
13. Tyler DJ, Hudsmith LE, Clarke K, Neubauer S, Robson MD,. A comparison of cardiac P-31 MRS at 1.5 and 3 T. NMR Biomed 2008; 21: 793-798.
14. Moser E, Stahlberg F, Ladd ME, Trattnig S,. 7-T MR-from research to clinical applications? NMR Biomed 2012; 25: 695-716.
15. Clarke WT,. Preliminary 7 Tesla human cardiac 31P magnetic resonance spectroscopy [MChem]. Oxford: University of Oxford; 2012. 65 p.
16. Schroeder JL, Tyler DJ, Emmanuel Y, Robson MD, Scheuermann-Freestone M, Neubauer S, Clarke K,. Effect of patient orientation on cardiac 31P-MRS. In Proceedings of the 14th Annual Meeting of ISMRM, Seattle, Washington, 2006. Abstract 3097.
17. Mitsch CC, Freedman LD, Moreland CG,. Substituent and solvent effects on P-31 NMR chemical shifts of substituted diethyl phenylphosphonates. J Magn Reson 1971; 5: 140.
18. El-Sharkawy AM, Schar M, Ouwerkerk R, Weiss RG, Bottomley PA,. Quantitative cardiac P-31 spectroscopy at 3 Tesla using adiabatic pulses. Magn Reson Med 2009; 61: 785-795.
19. British Standards Institute. Particular requirements for the basic safety and essential performance of magnetic resonance equipment for medical diagnosis. Medical electrical equipment. London: British Standards Institute; 2010.
20. Robson MD, Tyler DJ, Neubauer S,. Ultrashort TE chemical shift imaging (UTE-CSI). Magn Reson Med 2005; 53: 267-274.
21. Frauenrath T, Hezel F, Renz W, d'Orth TdG, Dieringer M, von Knobelsdorff-Brenkenhoff F, Prothmann M, Schulz-Menger J, Niendorf T,. Acoustic cardiac triggering: a practical solution for synchronization and gating of cardiovascular magnetic resonance at 7 Tesla. J Cardiovasc Magn Reson 2010; 12: 67.
22. Bottomley PA, Ouwerkerk R,. The dual-angle method for fast, sensitive T-1 measurement in-vivo with low-angle adiabatic pulses. J Magn Reson B 1994; 104: 159-167.
23. Look DC, Locker DR,. Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum 1970; 41: 250-251.
24. Rodgers CT, Piechnik SK, DelaBarre LJ, Van de Moortele P-F, Snyder CJ, Neubauer S, Robson MD, Vaughan JT,. Inversion recovery at 7 T in the human myocardium: measurement of T(1), inversion efficiency and B(1)(+). Magn Reson Med 2012; 70: 1038-1046.
25. Bogner W, Chmelik M, Schmid AI, Moser E, Trattnig S, Gruber S,. Assessment of (31)P relaxation times in the human calf muscle: a comparison between 3 T and 7 T in vivo. Magn Reson Med 2009; 62: 574-582.
26. Bogner W, Chmelik M, Andronesi OC, Sorensen AG, Trattnig S, Gruber S,. In vivo (31)P spectroscopy by fully adiabatic extended image selected in vivo spectroscopy: a comparison between 3 T and 7 T. Magn Reson Med 2011; 66: 923-930.
27. Tannus A, Garwood M,. Improved performance of frequency-swept pulses using offset-independent adiabaticity. J Magn Reson A 1996; 120: 133-137.
28. Luo Y, de Graaf RA, DelaBarre L, Tannus A, Garwood M,. BISTRO: an outer-volume suppression method that tolerates RF field inhomogeneity. Magn Reson Med 2001; 45: 1095-1102.
29. Vanhamme L, van den Boogaart A, Van Huffel S,. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997; 129: 35-43.
30. Stefan D, Di Cesare F, Andrasescu A, et al. Quantitation of magnetic resonance spectroscopy signals: the jMRUI software package. Meas Sci Technol 2009; 20.
31. Horn M, Kadgien M, Schnackerz K, Neubauer S,. P-31-nuclear magnetic resonance spectroscopy of blood: a species comparison. J Cardiovasc Magn Reson 2000; 2: 143-149.
32. Ernst RR, Anderson WA,. Application of Fourier transform spectroscopy to magnetic resonance. Rev Sci Instrum 1966; 37: 93.
33. Ernst RR, Bodenhausen G, Wokaun A,. Principles of nuclear magnetic resonance in one and two dimensions. Oxford: Clarendon Press; 1987. xxiv, 610 p.
34. Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron-Demilly D,. Cramer-Rao bounds: an evaluation tool for quantitation. NMR Biomed 2001; 14: 278-283.
35. Ross SM,. Introduction to probability and statistics for engineers and scientists. London: Elsevier Academic Press; 2004.
36. Redpath TW, Wiggins CJ,. Estimating achievable signal-to-noise ratios of MRI transmit-receive coils from radiofrequency power measurements: applications in quality control. Phys Med Biol 2000; 45: 217-227.
37. Schar M, El-Sharkawy AMM, Weiss RG, Bottomley PA,. Triple Repetition Time Saturation Transfer (TRiST) P-31 spectroscopy for measuring human creatine kinase reaction kinetics. Magn Reson Med 2010; 63: 1493-1501.
38. Bottomley PA, Hardy CJ, Weiss RG,. Correcting human heart P-31 NMR-spectra for partial saturation-evidence that saturation factors for PCR ATP are homogeneous in normal and disease states. J Magn Reson 1991; 95: 341-355.
39. Evelhoch JL, Ewy CS, Siegfried BA, Ackerman JJH, Rice DW, Briggs RW,. P-31 spin-lattice relaxation-times and resonance linewidths of rat-tissue in vivo-dependence upon the static magnetic-field strength. Magn Reson Med 1985; 2: 410-417.
40. L. Sudmeier J, E. Anderson S, S. Frye J,. Calculation of nuclear spin relaxation times. Concepts Magn Reson 1990; 2: 197-212.
41. Levitt MH,. Spin dynamics: basics of nuclear magnetic resonance. Chichester, England; John Wiley and Sons; 2008. xxv, 714 p, 717 p. of plates p.
42. Gaspar R, Brey WS, Qiu A, Andrew ER,. P-31 magnetic-relaxation of adenosine 5?-monophosphate, adenosine 5?-diphosphate and adenosine 5?-triphosphate in solution. Chem Phys Lett 1989; 156: 619-622.
43. Gaspar R, Andrew ER,. P-31 Magnetic-relaxation of inorganic orthophosphate in solution. Chem Phys Lett 1990; 170: 171-174.
44. Gaspar R, Brey WS, Andrew ER,. P-31 Magnetic-relaxation of phosphocreatine in solution. Chem Phys Lett 1991; 184: 17-20.
45. Meyerspeer M, Krssak M, Moser E,. Relaxation times of P-31-metabolites in human calf muscle at 3 T. Magn Reson Med 2003; 49: 620-625.
46. Nabuurs C, Huijbregts B, Wieringa B, Hilbers CW, Heerschap A,. P-31 saturation transfer spectroscopy predicts differential intracellular macromolecular association of ATP and ADP in skeletal muscle. J Biol Chem 2010; 285: 39588-39596.
47. Nabuurs CI, Hilbers CW, Wieringa B, Heerschap A,. Letter to the editor: "Interpretation of P-31 NMR saturation transfer experiments: do not forget the spin relaxation properties". Am J Physiol Cell Physiol 2012; 302: C1566-C1567.
48. Bottomley PA, Ouwerkerk R, Lee RF, Weiss RG,. Four-angle saturation transfer (FAST) method for measuring creatine kinase reaction rates in vivo. Magn Reson Med 2002; 47: 850-863.
49. Friedrich J, Nascimben L, Liao R, Ingwall JS,. Phosphocreatine-T(1) measurements with and without exchange in the heart. Magn Reson Med 1993; 30: 45-50.
50. Menon RS, Hendrich K, Hu XP, Ugurbil K,. P-31 NMR-spectroscopy of the human heart at 4-T-detection of substantially uncontaminated cardiac spectra and differentiation of subepicardium and subendocardium. Magn Reson Med 1992; 26: 368-376.
51. Hetherington HP, Luney DJE, Vaughan JT, Pan JW, Ponder SL, Tschendel O, Twieg DB, Pohost GM,. 3D P-31 Spectroscopic imaging of the human heart at 4.1-T. Magn Reson Med 1995; 33: 427-431.
52. Panda A, Jones S, Stark H, Raghavan RS, Sandrasegaran K, Bansal N, Dydak U,. Phosphorus liver MRSI at 3 T using a novel dual-tuned eight-channel 31P/1H coil. Magn Reson Med 2012; 68: 1346-1356.
53. Rodgers CT, Cochlin LE, Tyler DJ, Neubauer S, Robson MD,. Performance of a phased array for 31P cardiac MR spectroscopy. In Proceedings of the 18th Annual Meeting of ISMRM, Stockholm, Sweden, 2010. Abstract 1327.
54. Hardy CJ, Bottomley PA, Rohling KW, Roemer PB,. An NMR phased-array for human cardiac P-31 spectroscopy. Magn Reson Med 1992; 28: 54-64.
55. Schar M, El-Sharkawy A-MM, Weiss RG, Bottomley PA,. Triple Repetition Time Saturation Transfer (TRiST) (31)P spectroscopy for measuring human creatine kinase reaction kinetics. Magn Reson Med 2010; 63: 1493-1501.
56. Laistler E, Goluch S, Kuehne A, Meyerspeer M, Schmid AI, Sieg J, Herrmann T, Mallow J, Bernarding J, Moser E,. A form-fitted 3 channel 31P, two channel 1H transceive coil for calf muscle studies at 7T. In Proceedings of the 18th Annual Meeting of ISMRM, Salt Lake City, Utah, USA, 2013. Abstract 2782.
57. Vandobbenburgh JO, Lekkerkerk C, Vanechteld CJA, Debeer R,. Saturation correction in human cardiac P-31 MR spectroscopy at 1.5 T. NMR Biomed 1994; 7: 218-224.
58. Bottomley PA, Ouwerkerk R,. Optimum flip-angles for exciting NMR with uncertain T-1 values. Magn Reson Med 1994; 32: 137-141.
59. Neubauer S, Krahe T, Schindler R, et al. Direct measurement of spin-lattice relaxation-times of phosphorus metabolites in human myocardium. Magn Reson Med 1992; 26: 300-307.
60. Sakuma H, Nelson SJ, Vigneron DB, Hartiala J, Higgins CB,. Measurement of T1 relaxation-times of cardiac phosphate metabolites using BIR-4 adiabatic RF pulses and a variable nutation method. Magn Reson Med 1993; 29: 688-691.
61. Hollander JA, Evanochko WT, Dell'Italia L, Pohost GM,. 31P NMR T1 inversion recovery measurements of the human heart. In: Proceedings of the 12th Annual Meeting of ISMRM, New York, New York, USA, 1993. (abstract 1098).
62. den Hollander JA, Buchthal SD, Pohost GM,. 31P T1 measurements of the human heart at 4.1 Tesla by fast low-angle MRSI. In Proceedings of the 8th Annual Meeting of ISMRM, Denver, Colorado, USA, 2000. Abstract 134.
63. Yabe T, Mitsunami K, Inubushi T, Kinoshita M,. Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy. Circulation 1995; 92: 15-23.